Agreement includes an exclusive drone distribution license and an option to acquire a controlling interest in Motomea

NETANYA, Israel, Aug. 05, 2026 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a defense technology company building a portfolio of technologies to detect, analyze and respond to physical threats, today announced that it has acquired a 10% stake in M.E.A. Testing Systems Ltd. and Mea Motomova India (collectively “Motomea”), a developer of advanced electric motor testing and validation systems, including an exclusive license to develop and distribute drone testing solutions.

The investment is intended to strengthen BiomX’s ability to support increasingly integrated defense systems by adding access to specialized expertise in one of the most critical components of unmanned aerial platforms, electric propulsion. BiomX paid $50,000 in cash for the 10% stake in Motomea, as well as undertook to issue 1,300,000 restricted shares to Motomea’s ultimate majority owner, subject to obtaining regulatory and NYSE approval.

Electric motors are central to the performance of modern unmanned aerial systems, influencing flight time, payload capacity, maneuverability, stability and reliability. Defects or performance inconsistencies can reduce endurance, destabilize flight and increase the risk of system failure, making testing and validation critical throughout development and production…